Viewing Study NCT01497366


Ignite Creation Date: 2025-12-24 @ 4:39 PM
Ignite Modification Date: 2026-07-18 @ 11:27 PM
Study NCT ID: NCT01497366
Status: COMPLETED
Last Update Posted: 2014-04-02
First Post: 2011-12-19
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 3 Study of Sofosbuvir and Ribavirin
Sponsor: Gilead Sciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HCV genotype 2 (GT-2) View
None HCV genotype 3 (GT-3) View